Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.49 USD | +3.22% | -1.54% | -28.39% |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 105.5 | 144.5 | 137.3 | 244.2 | 224.8 | 161.9 | - | - |
Enterprise Value (EV) 1 | 105.5 | 144.5 | 137.3 | 244.2 | 224.8 | 161.9 | 161.9 | 161.9 |
P/E ratio | -3.2 x | -4.04 x | -4.92 x | -5.52 x | -4.42 x | -3.04 x | -7.28 x | 4.77 x |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | 16.5 x | 4.05 x | 1.66 x | 0.88 x |
EV / Revenue | - | - | - | - | 16.5 x | 4.05 x | 1.66 x | 0.88 x |
EV / EBITDA | -3.21 x | -4.83 x | - | -6.84 x | -4.11 x | -3.28 x | -6.67 x | 8.98 x |
EV / FCF | -3.28 x | -5.08 x | - | -7.06 x | -3.79 x | -3.24 x | -32.4 x | 3.24 x |
FCF Yield | -30.5% | -19.7% | - | -14.2% | -26.4% | -30.9% | -3.09% | 30.9% |
Price to Book | - | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 18,634 | 27,321 | 27,355 | 34,054 | 35,860 | 36,054 | - | - |
Reference price 2 | 5.660 | 5.290 | 5.020 | 7.170 | 6.270 | 4.490 | 4.490 | 4.490 |
Announcement Date | 3/24/20 | 3/23/21 | 3/22/22 | 3/22/23 | 3/13/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | 13.59 | 40.01 | 97.75 | 184.8 |
EBITDA 1 | -32.87 | -29.9 | - | -35.69 | -54.77 | -49.28 | -24.28 | 18.02 |
EBIT 1 | -32.9 | -29.93 | -25.82 | -36.16 | -55.4 | -51.31 | -15.36 | 43.92 |
Operating Margin | - | - | - | - | -407.53% | -128.24% | -15.71% | 23.76% |
Earnings before Tax (EBT) 1 | -33 | -32.21 | -28.03 | -36.84 | -54.81 | -55.81 | -20.61 | 41.54 |
Net income 1 | -33 | -32.21 | -28.03 | -36.84 | -54.81 | -58.86 | -26.21 | 39.91 |
Net margin | - | - | - | - | -403.22% | -147.12% | -26.81% | 21.6% |
EPS 2 | -1.770 | -1.310 | -1.020 | -1.300 | -1.420 | -1.477 | -0.6167 | 0.9420 |
Free Cash Flow 1 | -32.19 | -28.45 | - | -34.6 | -59.28 | -50 | -5 | 50 |
FCF margin | - | - | - | - | -436.14% | -124.97% | -5.12% | 27.05% |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - | 277.39% |
FCF Conversion (Net income) | - | - | - | - | - | - | - | 125.27% |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 3/24/20 | 3/23/21 | 3/22/22 | 3/22/23 | 3/13/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | 2.063 | 1.638 | 3.796 | 6.096 | 5.977 | 8.255 | 10.98 | 14.8 | 15.2 |
EBITDA 1 | - | - | - | - | - | - | - | - | -13.55 | -15.12 | -14.96 | -12.86 | -11.91 | -10.16 | -9.7 |
EBIT 1 | -5.905 | -6.721 | -7.24 | -9.421 | -9.995 | -9.502 | -11.55 | -13.75 | -14.84 | -15.26 | -15.59 | -13.7 | -12.47 | -10.36 | -10.2 |
Operating Margin | - | - | - | - | - | - | -560.06% | -839.19% | -390.91% | -250.28% | -260.86% | -166% | -113.59% | -70.01% | -67.11% |
Earnings before Tax (EBT) 1 | -6.552 | -7.318 | -7.731 | -9.697 | -10.16 | -9.248 | -11.21 | -14.15 | -15.63 | -13.81 | -16.8 | -14.91 | -13.71 | -11.6 | -11.8 |
Net income 1 | -6.552 | -7.318 | -7.731 | -9.697 | -10.16 | -9.248 | -11.21 | -14.15 | -15.63 | -13.81 | -17.4 | -15.81 | -14.73 | -12.52 | -11.8 |
Net margin | - | - | - | - | - | - | -543.38% | -864.1% | -411.85% | -226.57% | -291.15% | -191.54% | -134.12% | -84.57% | -77.63% |
EPS 2 | -0.2400 | -0.2700 | -0.2800 | -0.3500 | -0.3700 | -0.3000 | -0.3000 | -0.3600 | -0.4100 | -0.3500 | -0.4367 | -0.3950 | -0.3650 | -0.2833 | -0.2800 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 11/9/21 | 3/22/22 | 5/16/22 | 8/9/22 | 11/9/22 | 3/22/23 | 5/10/23 | 8/10/23 | 11/8/23 | 3/13/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow 1 | -32.2 | -28.5 | - | -34.6 | -59.3 | -50 | -5 | 50 |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex 1 | - | - | - | 0.02 | 0.04 | 2.55 | 2.55 | 5 |
Capex / Sales | - | - | - | - | 0.29% | 6.37% | 2.61% | 2.71% |
Announcement Date | 3/24/20 | 3/23/21 | 3/22/22 | 3/22/23 | 3/13/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.39% | 162M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- SCPH Stock
- Financials scPharmaceuticals Inc.